In June, thousands of diabetes scientists from around the world gathered in New Orleans for the American Diabetes Association (ADA) Scientific Meeting. Here are some of their updates. More from our ...

Dr Elizabeth Robertson, Diabetes UK's Director of Research and Clinical, shares her thoughts following the historic approval of the first type 1 diabetes immunotherapy on the NHS.

The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS for people with early-stage type 1 diabetes, marking the start of a new era in how we treat the ...

I received a letter stating that I was at an increased risk of developing type 2 diabetes, and that I’d have to book my HbA1c annually, and then it was entirely up to me as they don’t send reminders ...

Our new data shows type 2 diabetes is rising twice as fast in women under the age of 40 compared to women over 40. Save for later Page saved! You can go back to this later in your Diabetes and Me ...

New research has revealed the scale of stigma experienced by women with gestational diabetes, highlighting the significant toll on their wellbeing.

The way funding for hybrid closed loop technology works in Scotland is changing.

Dexcom are phasing out their Dexcom G6 continuous glucose monitor (CGM) and replacing it with the Dexcom G7.

We take a look at some of the exciting diabetes research developments announced in February 2026, and what the findings could mean for people living with or affected by diabetes.

Our landmark ELSA study (Early Surveillance for Autoimmune diabetes) has shown that childhood screening for type 1 diabetes works.

We welcome the introduction of UK-wide restrictions on junk food advertising, a key step towards tackling childhood obesity and reducing the risk of type 2 diabetes.

We take a look at some of the exciting diabetes research developments announced in November 2025, and what the findings could mean for people living with or affected by diabetes.